N

Neurocrine Biosciences
D

NBIX

143.200
USD
1.17
(0.82%)
مغلق
حجم التداول
41,637
الربح لكل سهم
7
العائد الربحي
-
P/E
38
حجم السوق
14,498,557,655
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    0.035
    (0.20%)
    17.560 USD
    A
    ALKS
    -0.270
    (-0.91%)
    29.480 USD
    A
    AVDL
    -0.25000
    (-3.13%)
    7.75000 USD
    E
    ESPR
    -0.05500
    (-2.44%)
    2.20000 USD
    I
    INSM
    -0.280
    (-0.38%)
    72.490 USD
    S
    SAGE
    0.10000
    (1.43%)
    7.07000 USD
    S
    SRPT
    1.070
    (0.91%)
    118.040 USD
    TEVA
    TEVA
    0.215
    (0.99%)
    21.920 USD
    المزيد
الأخبار
المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.